Dx Deals: Illumina to Acquire SomaLogic from Standard BioTools for $425M
The deal is expected to be a big boost for Illumina’s next-generation sequencing platforms
The deal is expected to be a big boost for Illumina’s next-generation sequencing platforms
The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
In a surprise move, the e-retail giant announced it will close down its Amazon Care Primary Health Services for employees at the end of 2022.
In July, ICATT took a major step toward equitable access to testing by enlisting two of the country’s leading COVID-19 PCR test providers.
Some of the lab industry’s biggest players are teaming up to develop new monkeypox diagnostics in response to the current outbreak.
A hostile government policy has done little to slow consolidation of independent medical practices and hospitals.
Companies will explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
Healthcare M&A might have bottomed out in the first quarter of 2022 in terms of both deal volume and size, according to a new report.
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.
A hot trend in capital raising for the healthcare and life sciences industries only two years ago, SPAC deals have petered out, but are far from dead.